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Changes in gene expression after temporary renal ischemia. Tempo-
rary renal ischemia is followed by increased DNA synthesis and cell
division as the kidney restores the continuity of the renal epithelium.
We sought to characterize some of the changes in proto-oncogene and
growth factor expression during this proliferative response. Northern
analysis of polyadenylated RNAs of kidney cortical and outer stripe of
outer medullary tissue from male Sprague-Dawley rats was performed
following release of renal hilar clamping of 50 minutes duration.
Ischemia produced an increase in c-fos mRNA that reached a peak at
one hour and declined rapidly to control levels by four hours after
release of the clamp. A similar rapid increase and decrease in early
growth response 1 (Egr 1) mRNA was noted. The response of these
immediate early genes was typical of their response to mitogens,
suggesting that they served a similar role in renal cell regeneration.
Levels of c-Ki-ras and glyceraldehyde phosphate dehydrogenase
mRNA were unchanged. Renal preproEGF mRNA decreased at two
hours, was virtually absent by 24 hours and remained low for at least
four days after ischemia. Urinary excretion of EGF fell immediately
after release of ischemia and before the decline in preproEGF mRNA or
SNGFR, suggesting post-transcriptional affects of ischemia on renal
EGF production. EGF excretion returned to only 50% of control by day
21. Specific 1251-EGF binding increased in membrane fractions of
cortex, outer medulla and inner medulla as early as 24 hours after
release of the clamp. Cortical '251-EGF binding increased in the
proximal tubule but not in the glomerulus. The later and more pro-
longed responses of the renal EGF system to ischemia may also be
involved in the renal regenerative response. These observations help to
identify several molecular events that accompany renal regeneration
after ischemic injury.
Recovery from ischemic and nephrotoxic acute renal failure
requires replacement of damaged tubular cells with new ones
that restore the continuity of the renal epithelium. In the
experimental model of acute renal failure produced by tempo-
rary occlusion of the renal pedicle, recovery is accompanied by
increased mitosis in renal epithelial cells, which is preceded by
increases in nucleic acid synthesis [1]. Similar increases in
DNA synthesis and mitotic activity have also been observed
following renal injury induced by mercury, gentamicin, folic
acid and cisplatin administration [2—5]. Little is known, how-
ever, about the control of renal regeneration after injury.
Quiescent cells stimulated to proliferate increase the tran-
scription of several genes, the so-called immediate early genes,
whose rates of transcription increase almost immediately after
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the addition of the growth promoting stimulus [6—91.One of the
earliest nuclear responses to such mitogens is the transcrip-
tional activation of the c-fos proto-oncogene, which occurs
within minutes after mitogenic stimulation and lasts only briefly
[81. Several genes with similar kinetic characteristics are also
activated [9], a subset of which, like c-fos, code for nuclear or
DNA binding proteins, examples of which include the c-jun
proto-oncogene [10] and the early growth response gene 1 [11,
12]. The products of these genes bind to DNA and presumably
initiate a cascade that provokes increased DNA synthesis and
cellular proliferation.
The proliferative response to renal cell injury should also
involve the activation of these immediate early genes. Liver
regeneration after partial hepatectomy and chemical injury [13,
14] is preceded by transient c-fos expression. In addition, if
these genes were to participate in renal regeneration, their
expression should be rapid, short-lived, and conclude before
the peak in DNA synthesis. Thus we measured the mRNA
abundance of several immediate early genes at various times
following release of renal ischemia to determine when their
expression took place in relationship to the onset of DNA
synthesis. As a previous study showed that ischemia reduced
preproEGF mRNA and EGF excretion [15], we also deter-
mined when these changes in EGF mRNA and EGF excretion
took place in relationship to the onset of increased DNA
synthesis. Finally, we determined whether changes in EGF
receptor density or affinity occurred in conjunction with re-
duced renal production of EGF.
Methods
General methods
Animal preparation. Rats undergoing ischemic renal failure
reduce food intake and lose weight. For this reason our studies
were performed under conditions of paired feeding to prevent
any differences in renal mRNA measurements secondary to
differences in food intake. All clearance experiments were
performed on Sprague-Dawley rats weighing 250 to 500 g,
housed in metal metabolic cages fitted with fine-mesh screens.
Each animal was offered 20 grams of a standard rat chow (Rat
Chow 5012, Ralston Purina Co., St. Louis, Missouri, USA,
containing 22.8% protein, 4.5% fat, 4.6% fiber and water) and
50 ml of tap water daily. After a period of four to six days, when
they ate their allotted portions of food, rats were anesthetized
(ketamine, 75 mg/kg) and both renal arteries were occluded for
50 minutes under sterile conditions. After release of the clamp,
the animals were placed in metal metabolic cages to collect
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urine. In sham operated animals, anesthesia, manipulation of
the renal hila, and exposure of the peritoneal cavity for 50
minutes was performed as in the ischemia studies, but occlusion
of the renal arteries was omitted. The daily consumption of food
and water was measured and urine was collected under oil in
plastic cylinders to which thymol was added. Each day the rats
were weighed and the 24-hour urine volume measured. A
portion of the urine was frozen and stored at —20°C for later
analysis of osmolality and EGF concentration. Blood was taken
by cardiac puncture under anesthesia before and on the first,
seventh and fourteenth day after ischemia. An additional two
rats were subjected to a similar ischemic period in only one
kidney, with the contralateral unclamped kidney serving as its
control. Animals were sacrificed at various times in the reflow
period as required by the specific protocols.
Clearance and micropuncture studies. In this study, the
acute effect of ischemia on the urinary excretion of EGF and
renal function was assessed in four pairs of ischemic and sham
animals. Animals were anesthetized with mactin (Andrew
Lockwood Associates, East Lansing, Michigan, USA) 100
mg/kg i.p. and placed on a heated surgical table. Body temper-
ature, monitored by a rectal temperature probe (Yellow Springs
Instrument Co., Yellow Springs, Ohio, USA) was maintained at
37 to 38°C. Polyethylene catheters were placed in the carotid
artery, jugular vein, the left ureter and the dome of the bladder.
The catheter placed in the carotid artery was used for blood
sampling and for measuring arterial pressure (AP) with a
strain-gauge transducer (Ailtech, City of Industry, California,
USA) connected to a recorder (Gould Inc., Cleveland, Ohio,
USA). After cannulation of the jugular vein, an infusion of
isotonic NaCl (125 mM)/NaHCO3 (25 mM) was begun at 1.0
mlIlOO g body weight/hr using a constant infusion pump (Sage,
Orion Research, Cambridge, Massachusetts, USA). The infu-
sion solution contained enough [methoxy-3Hjinulin (ICN Phar-
maceutical Co., Irvine, California, USA) to deliver 10 to 15 jiCi
per hour. Approximately 100 minutes after the infusions were
started, 150 p1 of blood was taken and the first of three 20 to 30
minute urine collections was begun. Blood samples were taken
at the midpoint of the clearance periods throughout the exper-
iment and spun immediately in a microcentrifuge to separate
plasma from blood cells. After the conclusion of the control
periods, the left renal artery was clamped for 50 minutes and
released, and the clearance measurements repeated for up to
four hours after reflow.
In two additional animals single nephron and whole kidney
glomerular filtration were measured together. After anesthesia
and placement of catheters in the jugular vein, carotid artery
and dome of the bladder, the left kidney was exposed through a
flank incision, carefully freed from the surrounding perirenal
fat, and supported in a plastic cup. Its surface was bathed with
mineral oil warmed to 38°C and illuminated with a fiber-optic
illuminator fitted with an infrared filter to minimize heat. The
inulin concentration of the NaCI/NaHCO3 infusion was ad-
justed to deliver 150 pCi of [methoxy-3H] inulin per hour.
Superficial proximal tubules were punctured at random using 8
to 10 m OD micropipettes. An oil block three to four tubule
diameters in length was injected prior to tubule fluid collections
and held in place when necessary by applying suction through
the collection pipet. Exactly timed (2 to 4 mm) collections of
tubule fluid were obtained in at least four nephrons during the
control period. At the conclusion of this period, the left and
right renal hila were occluded for 50 minutes. After release of
the clamps, SNGFR and clearance measurements were contin-
ued for up to 90 minutes after reflow.
RNA blot analysis. Relative levels of mRNA were analyzed
by Northern and dot-blot analysis. Total cortical RNA was
isolated from anesthetized animals at varying time periods after
renal ischemia (unilateral or bilateral) or sham operation by the
guanidinium thiocyante procedure [16] after intraarterial perfu-
sion of the kidney with cold 154 m'i NaC1, 50 m Tris (pH 7.4).
Poly(A) RNA was isolated by oligo(dT)-cellulose (Type 3,
Collaborative Research, Bedford, Massachusetts, USA) chro-
matography [17]. Poly(A) RNA (5 gig/lane) was either electro-
phoresed through formaldehyde- 1% agarose gels [18] and trans-
ferred overnight to nitrocellulose membranes (BA 85,
Schleicher and Schuell, Inc., Keene, New Hampshire, USA) as
described [19], or applied directly (1 pjg/lane) to the membranes
by filtration. Hybridization was carried out with nick translated
DNAs labeled with 32P-dCTP (500 Ci/mmol) to a specific
activity of approximately 5 x 108 cpmIig DNA [20]. Nitrocel-
lulose blots were prehybridized at 45°C overnight with dena-
tured salmon sperm DNA (0.1 mglml) in 5 X SSC, 50%
deionized formamide, and 0.02% Denhardt's solution (0.02%
ficoll, 0.02% polyvinylpyrrolidine, and 0.02% BSA) and hybrid-
ized at 45°C overnight in the same solution containing 10%
dextran sulfate and radiolabeled probe. Non-specifically bound
radioactivity was removed by extensive washing as described
[21]. After washing, the blots were air dried and exposed
overnight to Kodak XAR film at —70°C with intensifying
screens. Quantitative variabilities of either isolation or transfer
of RNAs were accounted for by reprobing the Northern blots
with a cDNA probe for glyceraldehyde-3-phosphate-dehydro-
genase. The sequences used for nick translation were excised
with appropriate restriction endonucleases and purified by
preparative gel electrophoresis. The cDNA for fos was a 1 kb
fragment of v-fos in pfos- 1 [22] and was purchased from ATCC
(Rockville, Maryland, USA). The cDNA probes for murine
preproEGF from plasmid pmegfl0 [23] and rat glyceraldehyde-
3-phosphate-dehydrogenase from prGAPDH-13 [24] were gifts
of the authors. The Egr-l probe was a 800 bp EcoRl fragment
from the non-finger region of Egr-1 (12) and was a gift of Vikas
Sukhatme.
'251EGF binding studies. Binding studies were performed in
150 to 250 g Sprague Dawley rats in which one renal artery was
clamped for 50 minutes, as described above. For membrane
preparations, cortex, outer medulla or inner medulla were
minced and homogenized with 15 strokes Potter-Elvehejem
homogenizer in hypotonic buffer (5 mrvi MgCl2, 10 mivi Tris, 16
mM Hepes, pH 7.4 with 100 LM PMSF and 0.1% trypsin
inhibitor). The suspension was centrifuged at 4°C at 1000 g for
10 minutes and the supernatant was then centrifuged at 15000
rpm for 20 minutes in a Beckman J2-2 1 high speed preparative
centrifuge with a JA 17 rotor. The fluffy plasma membranes
were removed from the pellet and resuspended and recentri-
fuged at 15000 rpm for 20 minutes. Proximal tubule suspensions
were prepared as previously described [25, 26]. Suspensions of
glomeruli were prepared by standard sieving techniques.
Binding studies were performed in a microfuge tube contain-
ing 40 p1 of membrane suspension, 160 p1 of phosphate buffered
saline (PBS), 1251-labelled mouse EGF (New England Nuclear,
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Boston, Massachusetts, USA) (150 to 175 Ci/sg) and receptor
grade (single HPLC peak) mouse EGF (Collaborative Re-
search, Waltham, Massachusetts, USA). Studies were per-
formed for 50 to 60 minutes at 23°C, by which time equilibrium
binding occurs [25]. The membrane suspensions were then
pelleted in a microfuge and subjected to three additional
washes. Membrane associated radioactivity was measured in a
gamma counter (Searle Analytic, Model 1197). Specific binding
was determined by subtracting the component of nonspecific
binding, measured in the presence of 1000-fold excess of
unlabelled EGF, from total 1251-EGF binding. Saturable binding
was determined by incubating membranes with 0.05 flM 125J
EGF in the presence of increasing concentrations of unlabelled
EGF.
3H-thymidine incorporation. Studies were performed in eight
ischemic (bilateral) and five sham-operated male rats weighing
150 to 425 g at various times after operation. Thirty minutes
before sacrifice the rats were injected with 3H-methyl thymidine
(0.5 CiIbody wt i.p.), anesthetized, and the kidneys flushed
with 0.9% NaCl intrarterially and removed. Portions of the
entire kidney were homogenized in 40 volumes (vol/wt) of 150
mM NaCI, 100 mri EDTA, pH 8. SDS was added to a final
concentration of 1% and mixed gently. NaClO4 was then added
to a final concentration of 1 M. The mixture was extracted 1:1
with phenol:isoamyl alcohol:chloroform (1:1:24) and spun at
5000 rpm for 10 minutes. Two and a half volumes of 95%
ethanol was then added to the supernatent and the DNA
precipitate removed by gentle stirring with a glass rod. After
washing with 75% ethanol, the DNA was disolved in 100 mM
NaCl, 50 mri Tris, pH 7.5, 5 mrsc EDTA at 37°C.
Analytical methods
Osmolality was measured by vapor pressure osmometry
(Wescor, Ogden, Utah, USA). Urine samples were assayed for
EGF receptor-binding activity in duplicate using membranes
from A43 1 cells as the source of receptors and highly purified
mouse EGF as 1251-labeled tracer and reference standard (Bio-
medical Technologies, Stoughton, Massachusetts, USA). A
standard curve using known concentrations of unlabeled mEGF
reference standard was included in each assay. Blood urea
nitrogen was measured on the first, seventh and fourteenth day
after ischemia or sham operation by the diacetyl monoxime
method [27]. 3H activity in urine, plasma, tubule fluid and
isolated DNA was determined in a liquid scintillation spectrom-
eter (Packard Tri-Carb model 2425, Downers Grove, Illinois,
USA). The concentration of DNA was determined spectropho-
tometrically (Lambda 3A, Perkin-Elmer, Norwalk, Connecti-
cut, USA).
Calculations
Whole kidney GFR and single nephron GFR were determined
by the ratio of the inulin activities in urine or tubule fluid and
plasma multiplied by the urine (mL/min) and tubule fluid (nLlmin)
flow rates, respectively.
Statistical analysis
The statistical significance of the results was assessed by
Student's (-test with paired and unpaired data as indicated.

















The effects of 50 minutes of bilateral renal artery occlusion on
urine volume and osmolality, and blood urea nitrogen are
summarized in Figure 1. After release of the occlusion, rats
were initially oliguric, followed by polyuria and a return to near
normal levels of daily urine excretion. Urine osmolality was
reduced throughout the period of observation, reaching the
lowest levels through the first few days after reflow, then
returning toward normal thereafter. Blood urea nitrogen in-
creased to a peak value of 94.1 4.8 mg% on day 1 after
ischemia and fell to 26.3 4.7 by day 7 and to 16.5 1.4 (N
2) by day 14. This form of bilateral renal artery occlusion and
release thus produced a partially reversible form of acute renal
failure. With rare exception, all rats that underwent ischemia
survived through the period of observation.
The results of the thymidine incorporation studies are sum-
marized in Figure 2. 3H-thymidine activity in kidney DNA was
unchanged at two hours, increasing more than 20-fold at 24
hours and returned toward baseline values at 96 hours after
reflow.
Northern transfer (Fig. 3A) and dot-blot analysis (Fig. 3B)
were performed on kidney mRNA isolated from ischemic rats.
c-fos, which is expressed at a relatively low level in the control









Fig. I. Mean daily urinary volume (A) and osmolality (B) in 6 pair-fed
ischemic (closed circles) and sham-operated (open circles) animals.
Mean blood urea nitrogen (C) at 1, 7 and 21 days in the ischemic
animals.
Time, days
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Fig. 2. 3H-thymidine/DNA specific activity (DPM/1igDNA) in whole
kidney DNA in sham (N = 5), and animals 2 hr (N = 3), 16 hr (N = 1),
24 hr (N = 2) and 96 hr (N = 2) after ischemia, P < 0.001. Shams that
were studied at 24 (N = 3) and 96 hr (N = 2) after operation showed
similar 3H-thymidine DNA specific activity and the results are com-
bined. They are plotted at zero-time.
2), decreased at two hours (lane 3) and returned to control
levels by four hours after ischemia. A similar rapid increase and
a slower decrease in Egr-I mRNA was noted (Fig. 3B). A minor
increase in c-myc mRNA was noted at four and six hours after
ischemia which returned to normal by 24 hours (data not
shown). No change in c-ras (data not shown), or GPDH (Fig.
3B) was observed.
PreproEGF mRNA fell at two hours (60% reduction) and
declined progressively to undetectable levels at 24 hours (Fig.
3B) and returned to only 1% of control by four days after
reflow. Similarly, preproEGF mRNA was not detectable in
kidney tissue 24 hours after release of 50 minutes of hilar
clamping of only one kidney, while the contralateral non-
ischemic kidney contained normal levels of preproEGF mRNA
(Fig. 4), indicating that the reduction was not a consequence of
uremia.
Urinary EGF excretion (Fig. 5) fell from a mean of 10.2 2.8
to 0.32 0.09 /Lglday (P < 0.001) within the first day and
remained markedly reduced for up to four days after ischemia.
Subsequently, urinary EGF excretion rose progressively, but at
21 days was still only 50% of the control daily excretion (9.82
1.34 vs. 5.49 0.43 tg/day, P < 0.001). The fall in EGF
excretion was rapid (Fig. 5, insert) with the rate of EGF
excretion reduced to 10% of control values within the first 25
minutes after release of the arterial clamp. The decrease of EGF
excretion rate could not be attributed to a decrease in SNGFR,
which was unchanged for at least the first 90 minutes after
release, 28 2 (control) vs. 28.5 2 (ischemic).
Specific '251-EGF binding increased in kidney membrane
fractions from the cortex and medulla (Fig. 6). In cortical
membranes from rats five days after ischemia, a 3.65 0.65
Fig. 3. Northern and dot-blot analysis of renal proto-oncogene mRNA
levels at varying time points after ischemia. A. Poly (Ak) RNA samples
(5 tg/lane) were isolated from male Sprague-Dawley rat kidney cortex
1 hr (lane 2), 2 hr (lane 3) 4 hr (lane 4) and 96 hr (lane 5) after ischemia
and 2 hr after sham operation (lane 1). The blots were hybridized using
a nick-translated c-DNA probe for v-fos (Methods). The scale on the left
is in kilobases (RNA ladder, BRL, Gaithersburg, Maryland, USA).
Northern analysis of mRNA samples isolated at 12 and 96 hr after sham
operation were also performed and revealed equal hybridization inten-
sity to that shown in the 2 hour sample. B. Dot blot analysis of poly (A)
RNA samples (1 pg/lane) isolated from male Sprague-Dawley rat
kidney cortex 1 hr (lane 2), 4 hr (lane 3), 6 hr (lane 4), 24 hr (lane 5), 48
hr (lane 6), and 96 hr (lane 7) after ischemia and 24 hr after sham
operation (lane I). The specific blots were hybridized with probes
specific for preproEGF, Egr-1, or GPDH.
Fig. 4. Northern analysis of preproEGF mRNA in unclamped (lane 1)
and clamped ischemic (lane 2) kidney 24 hours after unilateral renal
artery clamping. The mobility of 28 and 18 S RNA is shown on the left
and the cDNA probes on the right. The blot was sequentially hy-
bridyzed to probes specific for preproEGF and GAPDH (glyceralde-
hyde-3-phosphate dehydrogenase).














Fig. 5. Daily urinary EGF excretion after
ischemia. Mean values 1 SEM are shown.
Zero time value is mean daily excretion for
the 24 hour period prior to the renal artery
clamping or sham operation. Insert. Urinary
excretion of EGF immediately after release of
clamp in ischemic (closed circles) and
contralateral sham operated kidney. Zero-time
value is mean minute excretion for a 30
minute period before renal artery clamping.
Urine volumes from ischemic and control
kidneys were not significantly different.
(2.26 0.50 fold increase, N = 6; P < 0.05). A three-fold
increase in specific binding was also noted in outer medullary
membranes. Scatchard analysis revealed no alterations in high
affinity binding in membranes from ischemic animals (cortex:
0.418 0.09 vs. 0.378 0.117 nM; N = 6; inner medulla: 0.319
0.2 19 vs. 0.263 0.098; N = 4).
To characterize further the site(s) of increased EGF binding,
binding studies were performed on proximal tubule and glomer-
ular suspensions. Following ischemia, '251-EGF binding in
proximal tubules increased four-fold (Bmax 21.46 vs. 5.38 fmol/
mg protein; N = 6) while Km did not change (2.67 vs. 2.03 nm).
By contrast, there was minimal increase in glomerular '251-EGF
binding after ischemia (1.13 0.05 fold; N = 3).
Discussion
Time, hours
Fig. 6. A. '251-EGF binding to renal membranes 5 days after ischemia.
B. Changes in EGF binding in time following ischemia.
(N = 6, P < 0.005) fold increase was noted. No increase in
specific EGF binding was noted either immediately or four
hours after reflow, but significant increases were noted at 24
hours (4.78 0.91 fold increase; N = 3, P < 0.05; Fig. 6).
Similarly, inner medullary membranes demonstrated significant
increases in specific binding at one day after vascular clamping
Following ischemic injury, normally quiescent kidney cells
increase their rates of DNA synthesis (Fig. 2) and undergo
mitosis [1], thereby replacing those cells injuried by ischemia.
The present studies detail some of the changes in cellular gene
expression that accompany this mitogenic response.
We detected a marked increase in the mRNA for several
immediate early genes soon after the induction of ischemia (Fig.
2). c-fos and Egr-1 mRNA increased markedly to peak values
within the first hour of reflow well before the peak in DNA
synthesis; the increase was short-lived and levels returned to
normal by four hours (c-fos) and 24 hours (Egr-1) after release.
Such changes in c-fos and Egr-1 mRNA are typical of their
response to growth factors, suggesting that transcriptional
activation of these genes in response to ischemia is similar to
that after mitogenic stimulation of quiescent cells in culture [8,
11, 12, 28]. Induction of c-fos is independent of new protein
synthesis [291 and involves some modification of constitutively
expressed proteins, presumably by phosphorylation. Both pro-
tein kinase C and adenylate cyclase pathways have been
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identified, each represented by its unique binding domain within
the 5' flanking region of the gene. A third domain is necessary
for induction by calcium ionophores and membrane depolariz-
ing agents. The specific transduction signals activated by renal
ischemia and the particular cells transcribing these genes were
not explored in these studies and determining these issues
should provide greater insight into the process of repair.
Our studies detail several observations concerning renal EGF
after ischemia. Unlike the increase in cfos and Egr-1 mRNAs,
which was rapid and short-lived, the decline in preproEGF
mRNA was not immediate, and once established, lasted a long
time. The prolonged reduction of preproEGF mRNA is of
interest as the thick ascending limb and distal tubule, which are
the only sites of preproEGF mRNA production in the kidney,
undergo mild, reversible and transient morphologic changes
after ischemia [30, 311, so that the prolonged decline in mRNA
cannot be ascribed to the simple loss of cells that produce it.
Yet functional injury to the thick ascending limb may be more
severe than the morphological studies would suggest. For
example, the ability of the thick ascending limb of the loop of
Henle to generate a maximum transepithelial salt gradient is
reduced after ischemia [32, 33], and an increase in mitotic
figures in the meduilary thick ascending limb has been noted as
well [34]. Thus general reduction of thick ascending limb
mRNA synthesis after ischemia is possible. Alternatively, more
specific effects of ischemia on the synthesis and stability of
preproEGF mRNA should be considered. For example, it is
possible that transcription is negatively affected either by the
regenerative process itself or by interruption of EGF processing
and excretion. Interestingly, the same reciprocal relationship
between high rates of DNA synthesis and reduced EGF expres-
sion during ischemia is present in the immediate neonatal period
[35, 361, suggesting that when the kidney is committed to
proliferation, the expression of EGF is reduced. Consistent
with this notion are the observations that EGF is growth
inhibitory in several cell types [37—39] and retards the growth of
kidney and liver when administered to neonatal rats [40, 41]. A
somewhat parallel situation exists after liver injury induced by
carbon tetrachloride, where hepatic albumin gene expression
declines during its regeneration [421.
Urinary EGF excretion decreased much more rapidly than
EGF mRNA (Figs. 3B and 5) and preceded the decline in
SNGFR. Thus, it seems likely that, in addition to its transcrip-
tional effects, ischemia affected EGF post-transcriptionally as
well. Reduced EGF excretion and renal EGF production was
followed by increased EGF receptor density. The increase was
not limited solely to regenerating regions of the kidney but
occurred in both cortical and inner medullary membranes.
These observations suggest that urinary EGF may play a role in
regulating renal EGF receptor density. The increase in EGF
receptor density may also be a direct response to mitogenic
stimulation. The significance of these changes in EGF receptor
density is unknown but, as circulating levels of EGF would not
be affected by the loss of renal EGF production, the up-
regulation of the renal EGF receptor might augment renal EGF
actions including increased renal vasoconstriction [43], dimin-
ished water reabsorption [44], and enhanced mitogenesis [45,
46] all of which characterize the kidney during recovery from
ischemic renal failure.
In summary, ischemia has wide ranging effects on gene
transcription in the kidney. At least two members of the
immediate early genes, c-fos and Egr-1, are stimulated with
kinetic responses typical of their response to mitogenic stimuli.
Their elevation preceds the start of increased renal DNA
synthesis, suggesting that they are early determinants of renal
cell regeneration after injury. Ischemia also produced pro-
longed reduction of EGF excretion and preproEGF mRNA
which also preceeded the increase in DNA synthesis. Ischemia
was accompanied by increased EGF receptor density. Further
studies into how the immediate early genes are activated and
identifying their sites of synthesis during ischemia, as well as
exploring the relationship between these changes and the
changes in the renal EGF system should yield important new
insights into the molecular basis for renal regeneration after
ischemic injury.
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